Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 1
Results: 13
In Memoriam.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 6, doi. 10.1002/cpdd.910
- Publication type:
- Article
Starting the Tenth Year.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 7, doi. 10.1002/cpdd.900
- By:
- Publication type:
- Article
Population Pharmacokinetic Analysis of BMS‐986166, a Novel Selective Sphingosine‐1‐Phosphate‐1 Receptor Modulator, and Exposure‐Response Assessment of Lymphocyte Counts and Heart Rate in Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 8, doi. 10.1002/cpdd.878
- By:
- Publication type:
- Article
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 86, doi. 10.1002/cpdd.865
- By:
- Publication type:
- Article
Effects of ABCB1, UGT1A1, and UGT1A9 Genetic Polymorphisms on the Pharmacokinetics of Sitafloxacin Granules in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 57, doi. 10.1002/cpdd.848
- By:
- Publication type:
- Article
Effect of Itraconazole, a Potent CYP3A4 Inhibitor, on the Steady‐State Pharmacokinetics of Vemurafenib in Patients With BRAF<sup>V600</sup> Mutation–Positive Malignancies.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 39, doi. 10.1002/cpdd.822
- By:
- Publication type:
- Article
Effect of Mild and Moderate Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of a Single Dose of Oral Ivosidenib in Otherwise Healthy Participants.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 99, doi. 10.1002/cpdd.821
- By:
- Publication type:
- Article
A Randomized, Single‐Blind, Placebo‐Controlled, 3‐Way Crossover Study to Evaluate the Effect of Therapeutic and Supratherapeutic Doses of Edaravone on QT/QTc Interval in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 46, doi. 10.1002/cpdd.814
- By:
- Publication type:
- Article
Evaluation of the Pharmacokinetics, Pharmacodynamics, and Safety of a Single Dose of Emicizumab in Healthy Chinese Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 30, doi. 10.1002/cpdd.805
- By:
- Publication type:
- Article
Effects of Vitamin D Receptor, Cytochrome P450 3A, and Cytochrome P450 Oxidoreductase Genetic Polymorphisms on the Pharmacokinetics of Remimazolam in Healthy Chinese Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 22, doi. 10.1002/cpdd.797
- By:
- Publication type:
- Article
Exposure‐Response Analysis to Assess the Concentration‐QTc Relationship of Psilocybin/Psilocin.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 78, doi. 10.1002/cpdd.796
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Ursodeoxycholic Acid in an Overweight Population With Abnormal Liver Function.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 68, doi. 10.1002/cpdd.790
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 1, p. 1, doi. 10.1002/cpdd.708
- Publication type:
- Article